- Home
- TCBX vs SVRA Comparison
TCBX vs SVRA Comparison
Compare TCBX & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- SVRA
- Stock Information
- Founded
- TCBX 2008
- SVRA 2007
- Country
- TCBX United States
- SVRA United States
- Employees
- TCBX N/A
- SVRA N/A
- Industry
- TCBX Banks
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- SVRA Health Care
- Exchange
- TCBX Nasdaq
- SVRA Nasdaq
- Market Cap
- TCBX 454.9M
- SVRA 505.8M
- IPO Year
- TCBX 2021
- SVRA N/A
- Fundamental
- Price
- TCBX $30.97
- SVRA $2.92
- Analyst Decision
- TCBX Hold
- SVRA Buy
- Analyst Count
- TCBX 4
- SVRA 6
- Target Price
- TCBX $33.67
- SVRA $8.83
- AVG Volume (30 Days)
- TCBX 72.3K
- SVRA 598.8K
- Earning Date
- TCBX 04-23-2025
- SVRA 05-16-2025
- Dividend Yield
- TCBX N/A
- SVRA N/A
- EPS Growth
- TCBX 44.43
- SVRA N/A
- EPS
- TCBX 2.95
- SVRA N/A
- Revenue
- TCBX $172,270,000.00
- SVRA N/A
- Revenue This Year
- TCBX $17.61
- SVRA N/A
- Revenue Next Year
- TCBX $6.52
- SVRA N/A
- P/E Ratio
- TCBX $10.50
- SVRA N/A
- Revenue Growth
- TCBX 17.40
- SVRA N/A
- 52 Week Low
- TCBX $18.82
- SVRA $2.26
- 52 Week High
- TCBX $39.45
- SVRA $5.31
- Technical
- Relative Strength Index (RSI)
- TCBX 54.59
- SVRA 56.79
- Support Level
- TCBX $29.60
- SVRA $2.81
- Resistance Level
- TCBX $31.12
- SVRA $3.56
- Average True Range (ATR)
- TCBX 1.45
- SVRA 0.18
- MACD
- TCBX 0.33
- SVRA -0.01
- Stochastic Oscillator
- TCBX 91.50
- SVRA 57.77
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.